Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study.
Akkerman O, Aleksa A, Alffenaar JW, Al-Marzouqi NH, Arias-Guillén M, Belilovski E, Bernal E, Boeree MJ, Borisov SE, Bruchfeld J, Cadiñanos Loidi J, Cai Q, Caminero JA, Cebrian Gallardo JJ, Centis R, Codecasa LR, D'Ambrosio L, Dalcolmo M, Danila E, Dara M, Davidavičienė E, Davies Forsman L, De Los Rios Jefe J, Denholm J, Duarte R, Elamin SE, Ferrarese M, Filippov A, Ganatra S, Garcia A, García-García JM, Gayoso R, Giraldo Montoya AM, Gomez Rosso RG, Gualano G, Hoefsloot W, Ilievska-Poposka B, Jonsson J, Khimova E, Kuksa L, Kunst H, Laniado-Laborín R, Li Y, Magis-Escurra C, Manfrin V, Manga S, Marchese V, Martínez Robles E, Maryandyshev A, Matteelli A, Migliori GB, Mullerpattan JB, Munoz-Torrico M, Mustafa Hamdan H, Nieto Marcos M, Noordin NM, Palmero DJ, Palmieri F, Payen MC, Piubello A, Pontali E, Pontarelli A, Quirós S, Rendon A, Skrahina A, Šmite A, Solovic I, Sotgiu G, Souleymane MB, Spanevello A, Stošić M, Tadolini M, Tiberi S, Udwadia ZF, van den Boom M, Vescovo M, Viggiani P, Visca D, Zhurkin D, Zignol M; members of the International Study Group on new anti-tuberculosis drugs and adverse events monitoring. Akkerman O, et al. Int J Infect Dis. 2019 Jun;83:72-76. doi: 10.1016/j.ijid.2019.03.036. Epub 2019 Apr 3. Int J Infect Dis. 2019. PMID: 30953827 Free article.
Prevention and treatment of tuberculosis infection in candidates for biologic therapy: A multidisciplinary consensus statement adapted to the dermatology patient.
Rodríguez-Jiménez P, Mir-Viladrich I, Chicharro P, Solano-López G, López-Longo FJ, Taxonera C, Sánchez-Martínez P, Martínez-Lacasa X, García-Gasalla M, Dorca J, Arias-Guillén M, García-García JM, Dauden E. Rodríguez-Jiménez P, et al. Actas Dermosifiliogr (Engl Ed). 2018 Sep;109(7):584-601. doi: 10.1016/j.ad.2018.03.013. Epub 2018 Jun 2. Actas Dermosifiliogr (Engl Ed). 2018. PMID: 29871738 English, Spanish.
Clinical and Epidemiological Correlates of Low IFN-Gamma Responses in Mitogen Tube of QuantiFERON Assay in Tuberculosis Infection Screening During the COVID-19 Pandemic: A Population-Based Marker of COVID-19 Mortality?
Palacios-Gutiérrez JJ, Rodríguez-Guardado A, Arias-Guillén M, Alonso-Arias R, Palacios-Penedo S, García-García JM, Balbín M, Pérez-Hernández D, Sandoval-Torrientes M, Torreblanca-Gil A, Melón S, Asensi-Álvarez V, Clain JM, Escalante P. Palacios-Gutiérrez JJ, et al. Arch Bronconeumol. 2022 Sep;58(9):649-659. doi: 10.1016/j.arbres.2022.01.011. Epub 2022 Feb 13. Arch Bronconeumol. 2022. PMID: 35185258 Free PMC article. Review.
New Research Strategies in Latent Tuberculosis Infection.
Escalante P, Arias-Guillén M, Palacios Gutiérrez JJ. Escalante P, et al. Arch Bronconeumol (Engl Ed). 2021 Mar;57(3):151-153. doi: 10.1016/j.arbres.2020.01.024. Epub 2020 Mar 17. Arch Bronconeumol (Engl Ed). 2021. PMID: 32192764 English, Spanish. No abstract available.
Consensus Document on Prevention and Treatment of Tuberculosis in Patients for Biological Treatment.
Mir Viladrich I, Daudén Tello E, Solano-López G, López Longo FJ, Taxonera Samso C, Sánchez Martínez P, Martínez Lacasa X, García Gasalla M, Dorca Sargatal J, Arias-Guillén M, García García JM. Mir Viladrich I, et al. Arch Bronconeumol. 2016 Jan;52(1):36-45. doi: 10.1016/j.arbres.2015.04.016. Epub 2015 Jul 14. Arch Bronconeumol. 2016. PMID: 26187708 English, Spanish.
New Perspectives in Latent Tuberculosis Infection.
Arias-Guillén M, Escalante P, Palacios Gutiérrez JJ. Arias-Guillén M, et al. Arch Bronconeumol (Engl Ed). 2020 Feb;56(2):74-75. doi: 10.1016/j.arbres.2019.07.009. Epub 2019 Aug 9. Arch Bronconeumol (Engl Ed). 2020. PMID: 31405608 Free PMC article. No abstract available.
Risk factors for tuberculosis in inflammatory bowel disease: anti-tumor necrosis factor and hospitalization.
Riestra S, de Francisco R, Arias-Guillén M, Saro C, García-Alvarado M, Duque JM, Palacios JJ, Muñoz F, Blanco L, Castaño O, Pérez-Martínez I, Martínez-Camblor P, Pérez Hernández D, Suárez A. Riestra S, et al. Rev Esp Enferm Dig. 2016 Sep;108(9):541-9. doi: 10.17235/reed.2016.4440/2016. Rev Esp Enferm Dig. 2016. PMID: 27604582 Free article.
Severe asthma and bronchiectasis.
García-Clemente M, Enríquez-Rodríguez AI, Iscar-Urrutia M, Escobar-Mallada B, Arias-Guillén M, López-González FJ, Madrid-Carbajal C, Pérez-Martínez L, Gonzalez-Budiño T. García-Clemente M, et al. J Asthma. 2020 May;57(5):505-509. doi: 10.1080/02770903.2019.1579832. Epub 2019 Feb 20. J Asthma. 2020. PMID: 30784336
Advances in the diagnosis of tuberculosis infection.
Arias Guillén M. Arias Guillén M. Arch Bronconeumol. 2011 Oct;47(10):521-30. doi: 10.1016/j.arbres.2011.06.018. Epub 2011 Sep 7. Arch Bronconeumol. 2011. PMID: 21903320 Review. English, Spanish.
68 results